SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-034911
Filing Date
2020-07-30
Accepted
2020-07-30 20:23:52
Documents
4
Period of Report
2020-07-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 2020 PUBLIC OFFERING snss-8k_20200729.htm 8-K 41466
2 EX-1.1 UNDERWRITING AGREEMENT snss-ex11_21.htm EX-1.1 309461
3 EX-5.1 OPINION snss-ex51_7.htm EX-5.1 15242
4 GRAPHIC gnwsguguwgnp000001.jpg GRAPHIC 32197
  Complete submission text file 0001564590-20-034911.txt   411902
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 201063036
SIC: 2834 Pharmaceutical Preparations